Loading...
Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination
We have assessed the immune-regulatory and adjuvant activities of a synthetic glycolipid, ABX196, a novel analog of the parental compound α-GalCer. As expected, ABX196 demonstrated a measurable and significant adjuvant effect in mice and monkeys with no appreciable toxicity at the doses used to prom...
Na minha lista:
| Udgivet i: | Vaccine |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233108/ https://ncbi.nlm.nih.gov/pubmed/25218293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.08.070 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|